AI Science Tracker

Tulane University

1 discovery from 2025

Discoveries

Machine learning uncovers new small-molecule chloride transporters from DrugBank

After high-throughput testing 1,894 compounds and confirming 59 chloride transporters, researchers trained and evaluated machine-learning classifiers, then prioritized DrugBank compounds for wet-lab tests. Five of ten selected drugs—bazedoxifene, centhaquine, brilliant green, tamoxifen and nevanimibe—were classified by the authors as active chloride transporters, with an estimated 50–60% hit rate under their assays.

Technology: Machine-learning binary classifiers and consensus QSAR models trained on experimentally measured chloride-transport activity

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: After high-throughput testing 1,894 compounds and confirming 59 chloride transporters, researchers trained and evaluated machine-learning classifiers, then prioritized DrugBank compounds for wet-lab tests.
  • Still unknown: The paper combines a large primary high-throughput screen with a later ML-led DrugBank virtual screen; do not attribute all 59 initial hits to ML. The five drug-repurposing hits were measured in artificial liposome assays, not cells, animals or patients. The paper discusses assay artifacts: quinacrine/brilliant green interfere with the fluorescent assay, HCl salts can affect electrode readings, and evidence for brilliant green was weaker than for the other confirmed compounds. Authors report 5/10 active among selected candidates (or 7/12 including two known active compounds), not a generalizable clinical hit rate.
  • AI role: After initial experimental discovery data were collected, machine-learning models ranked DrugBank candidates for transport activity. Researchers synthesized no new candidates for the virtual screen; instead, they tested ten prioritized available compounds in liposome chloride-transport assays. Five were classed as active; results extend these compounds' known pharmacology with membrane chloride transport activity.

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12368578/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: at percentile 56 of works of the same type, year and subfield (OpenAlex work metrics, 2 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.